Latest Data & Signals Issued

Signal Type Signal Value Data
Score -5.127 61 days ( 65.52 % )
Last Price $0.662 -2.65 %
High/ Low $0.660 - $0.702 4.94%
Chg 7 Days -1.21 % $0.670 $0.662
Chg 30 Days -54.97 % $1.47 $0.662
Chg 12 mos -14.81 % $0.777 $0.662
Trend - 3 mos -62.48 % Width: 116.31 %
Trend - 12 mos 48.38 % Width: 415.44 %
Pred. range - 3 mos $0.157 - $0.339 -76.34 % - -48.82 %
Pred. range - 12 mos $0.98 - $5.06 48.38 % - 664.82 %
Short MA avg 3 mos Sell Jul 02, 2024 - 2 days
Long MA avg 3 mos Sell Nov 30, -1 - N/A days
Short/Long MA avg 3 mos Sell Nov 30, -1 - N/A days
Short MA avg 12 mos Buy May 06, 2024 - 41 days
Long MA avg 12 mos Sell May 09, 2024 - 38 days
Short/Long MA avg 12 mos Sell May 13, 2024 - 36 days
Pivot Short Sell May 09, 2024 - 38 days
Bollinger Buy Feb 06, 2024 - 103 days
MACD Buy No Dates Stored For This Signal

Signals Effectiveness

Backtesting is not only a way to check stock signal accuracy, but also a tool to continually improvement. Data can be used for self adjustment as each stock has an individual behavior.

Accuracy and return is not the same. A stock signal may provide low statistical accuracy, but the signals may prove high return in average.

Sharp market dips or fundamental changes (earning reports, news updates etc), may force a short term reaction and disturb the signals (Signals may jump quickly from buy to sell, just to return to buy).

Stock Score

Buy Signals
Sell Signals

Bollinger Bands

Buy Signals
Sell Signals

MACD

Buy Signals
Sell Signals

Moving Average (7d)

Buy Signals
Sell Signals
Click to get the best stock tips daily for free!

About Equillium Inc.

Equillium. Equillium, Inc., a clinical-stage biotechnology company, develops and sells products to treat severe autoimmune and inflammatory, or immuno-inflammatory disorders with unmet medical need. The company's lead product candidate is itolizumab (EQ001), a clinical-stage monoclonal antibody that targets the novel immune checkpoint receptor CD6, which is in Phase III clinical trials for the treatment of acute graft-versus-host disease; completed Phase Ib... EQ Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT